TI
IMGO

Trexquant Investment’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Trexquant Investment’s Portfolio IMGO Stock Details IMGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-32,045
Closed -$429K – 1951
2022
Q2 		$429K Buy
+32,045
New +$509K 0.02% 917

Other funds holding IMGO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Trexquant Investment's IMGO Position: Q3 2022 in Review

Trexquant Investment sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q3 2022, closing a stake of 32,045 shares — an estimated $429K sold.

Trexquant Investment first reported a position in IMGO in Q2 2022 and held it in 1 quarter. The position peaked at $429K in Q2 2022. 65 funds tracked by Wall St. Rank hold IMGO as of Q3 2022.

  • Trexquant Investment reported no remaining Imago BioSciences, Inc. Common stock position as of Q3 2022 after selling out during the quarter.
  • Trexquant Investment sold 32,045 Imago BioSciences, Inc. Common stock shares in Q3 2022, an estimated $429K.
  • Trexquant Investment first reported a position in Imago BioSciences, Inc. Common stock in Q2 2022 and held it in 1 quarter.
  • Trexquant Investment's Imago BioSciences, Inc. Common stock position peaked at $429K in Q2 2022.
  • 65 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q3 2022.

Based on Trexquant Investment's 13F filing for Q3 2022, filed 14 Nov 2022.